BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxycycline
,
rs7903146
,
BRCA1
,
glucose metabolic process
,
Leukemia
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SLAMF7
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
T Lymphocyte (CD8+) of peripheral blood
Microglial cell
Stomach
Skeletal muscle psoas
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Disease caused by rickettsiae
Listeriosis
Multiple-resistant Staphylococcus aureus infection
Viral infections of the central nervous system
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Immunoglobulin Fab Fragments
Inactivated C3b
SP600125
IgG1
Macrocyclic Compounds
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TRAPPC3
TENM1
MAP3K7
BAZ1B
FGFR1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis.
SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
Signaling Lymphocytic Activation Molecule Family-7 Alleviates Corneal Inflammation by Promoting M2 P…
SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-t…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAM…
Pilot Study of SLAMF7 BATs/CS-1 BATs in Relapsed/Refractory Multiple Myeloma
2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-S…
Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ